NASDAQ: NCEL
Newcelx Ltd Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their NCEL stock forecasts and price targets.

Forecast return on equity

Is NCEL forecast to generate an efficient return?

Company
-6.61%
Industry
-23.83%
Market
365.04%
NCEL's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is NCEL forecast to generate an efficient return on assets?

Company
-4.39%
Industry
8.22%
NCEL is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

NCEL earnings per share forecast

What is NCEL's earnings per share in the next 1 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.46

NCEL revenue forecast

What is NCEL's revenue in the next 1 years based on estimates from 3 analysts?

Avg 1 year Forecast
$0.0

NCEL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
NCEL$4.01N/AN/A
ENVB$6.11N/AN/A
SPRC$2.75N/AN/A
AZTR$0.39N/AN/A
PBM$2.31N/AN/A

Newcelx Stock Forecast FAQ

What is NCEL's earnings growth forecast for 2025-2025?

(NASDAQ: NCEL) Newcelx's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.

Newcelx's earnings in 2025 is -$9,335,043.

In 2025, NCEL is forecast to generate -$190,580 in earnings, with the lowest earnings forecast at -$183,106 and the highest earnings forecast at -$196,185.

If you're new to stock investing, here's how to buy Newcelx stock.

What is NCEL's revenue growth forecast for 2025-2025?

(NASDAQ: NCEL) Newcelx's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Newcelx's revenue in 2025 is $0.

In 2025, NCEL is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is NCEL's forecast return on assets (ROA) for 2025-2025?

(NASDAQ: NCEL) forecast ROA is -4.39%, which is lower than the forecast US Biotechnology industry average of 8.22%.

What is NCEL's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: NCEL) Newcelx's current Earnings Per Share (EPS) is -$8.20. In 2025, NCEL's EPS is forecast to hit -$0.46 (min: -$0.44, max: -$0.47).

What is NCEL's forecast return on equity (ROE) for 2025-2025?

(NASDAQ: NCEL) forecast ROE is -6.61%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.